Cargando…

Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond

Glioblastoma multiforme (GBM), a highly invasive and incurable tumor, is the humans’ foremost, commonest, and deadliest brain cancer. As in other cancers, distinct combinations of genetic alterations (GA) in GBM induce a diversity of metabolic phenotypes resulting in enhanced malignancy and altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Khayari, Abdellatif, Bouchmaa, Najat, Taib, Bouchra, Wei, Zhiyun, Zeng, Ailiang, El Fatimy, Rachid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329787/ https://www.ncbi.nlm.nih.gov/pubmed/35912242 http://dx.doi.org/10.3389/fonc.2022.901951

Ejemplares similares

Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism
por: Zeng, Ailiang, et al.
Publicado: (2020)

In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
por: Bouchmaa, Najat, et al.
Publicado: (2023)

Synergistic antioxidant effects of natural compounds on H(2)O(2)-induced cytotoxicity of human monocytes
por: Ben Mrid, Reda, et al.
Publicado: (2022)

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco
por: Senhaji, Nadia, et al.
Publicado: (2017)

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
por: Haider, Ali S., et al.
Publicado: (2023)

Editorial: Metabolic Rewiring in Leukemias
por: Noguera, Nelida I., et al.
Publicado: (2021)

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation
por: Liu, Aizhen, et al.
Publicado: (2016)

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
por: Liu, Yu-Qing, et al.
Publicado: (2019)

The Impact of Surgery in IDH 1 Wild Type Glioblastoma in Relation With the MGMT Deregulation
por: Marchi, Francesco, et al.
Publicado: (2020)

The Prognostic Value of NANO Scale Assessment in IDH-Wild-Type Glioblastoma Patients
por: Kasper, Johannes, et al.
Publicado: (2021)

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population
por: Muracciole, Xavier, et al.
Publicado: (2018)

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
por: van Genugten, Evelien A. J., et al.
Publicado: (2022)

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
por: van Gisbergen, Marike W., et al.
Publicado: (2021)

KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
por: Pupo, Emanuela, et al.
Publicado: (2019)

Reactive Oxygen Species Rewires Metabolic Activity in Acute Myeloid Leukemia
por: Robinson, Andrew J., et al.
Publicado: (2021)

Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
por: Lee, Haksoo, et al.
Publicado: (2022)

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
por: Viswanath, Pavithra, et al.
Publicado: (2016)

Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma
por: Jiang, Haihui, et al.
Publicado: (2021)

The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma
por: Incekara, Fatih, et al.
Publicado: (2020)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

Distribution and favorable prognostic implication of genomic EGFR alterations in IDH ‐wildtype glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022)

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation
por: Incekara, Fatih, et al.
Publicado: (2020)

Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
por: Guo, Jianshuang, et al.
Publicado: (2019)

Assessment of Pre-operative Measurements of Tumor Size by MRI Methods as Survival Predictors in Wild Type IDH Glioblastoma
por: Palpan Flores, Alexis, et al.
Publicado: (2020)

The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in IDH Wild-Type Glioblastoma
por: Kaye, Brandon, et al.
Publicado: (2023)

Co-cultures of Glioma Stem Cells and Primary Neurons, Astrocytes, Microglia, and Endothelial Cells for Investigation of Intercellular Communication in the Brain
por: Wei, Zhiyun, et al.
Publicado: (2019)

Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma
por: Hashimoto, Ari, et al.
Publicado: (2022)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Genetic diversity for agromorphological traits, phytochemical profile, and antioxidant activity in Moroccan sorghum ecotypes
por: Bouargalne, Youssef, et al.
Publicado: (2022)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Updates in IDH-Wildtype Glioblastoma
por: Melhem, Jawad M., et al.
Publicado: (2022)

EGFR alterations in glioblastoma play a role in antitumor immunity regulation
por: Li, Xiao-Peng, et al.
Publicado: (2023)

Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?
por: Montella, Liliana, et al.
Publicado: (2022)

IDH3α regulates one-carbon metabolism in glioblastoma
por: May, Jasmine L., et al.
Publicado: (2019)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
por: Ruiz-Rodado, Victor, et al.
Publicado: (2022)

SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling
por: Song, Hai, et al.
Publicado: (2021)

S645C Point Mutation Suppresses Degradation of EGFR to Promote Progression of Glioblastoma
por: Huang, Wenda, et al.
Publicado: (2022)

The Glioblastoma Microenvironment: Morphology, Metabolism, and Molecular Signature of Glial Dynamics to Discover Metabolic Rewiring Sequence
por: Virtuoso, Assunta, et al.
Publicado: (2021)

Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma
por: Valtorta, Silvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o5fe3igmoalnjbrgh3t3etvl9p